Who makes Shz QIV 0.5 mL, single dose?

Shz QIV 0.5 mL, single dose is developed by Sanofi Pasteur, a Sanofi Company.

What development phase is Shz QIV 0.5 mL, single dose in?

Shz QIV 0.5 mL, single dose is in Phase 1.

Last reviewed 2026-05-14 · How we verify

Shz QIV 0.5 mL, single dose

Sanofi Pasteur, a Sanofi Company · Phase 1 active Biologic

At a glance

Generic name	Shz QIV 0.5 mL, single dose
Sponsor	Sanofi Pasteur, a Sanofi Company
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Safety of a Single Dose or Two Doses of Shenzhen Quadrivalent Influenza Vaccine (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Shz QIV 0.5 mL, single dose CI brief — competitive landscape report
Shz QIV 0.5 mL, single dose updates RSS · CI watch RSS
Sanofi Pasteur, a Sanofi Company portfolio CI